10 July 2015: Articles
Gastric Bezoar Treatment by Endoscopic Fragmentation in Combination with Pepsi-Cola® Administration
Unusual setting of medical care, Unexpected drug reaction, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Masaya Iwamuro ABEF , Naoko Yunoki BD , Jun Tomoda B , Kazuhiro Nakamura B , Hiroyuki Okada CD , Kazuhide Yamamoto CDDOI: 10.12659/AJCR.893786
Am J Case Rep 2015; 16:445-448
Abstract
BACKGROUND: Although bezoar dissolution by Coca-Cola® has been described in case reports and case series, to the best of our knowledge, the usefulness of other cola products such as Pepsi-Cola® has never been reported in the English literature.
CASE REPORT: An 86-year-old Taiwanese man was diagnosed with a gastric bezoar. Endoscopic fragmentation with a polypectomy snare was attempted twice but failed to remove the bezoar. Subsequently, 500 mL of Pepsi NEX Zero® was administered daily for 4 days via nasogastric tube. The bezoar was softened and successfully fragmented by the polypectomy snare and needle-knife devices on the third attempt.
CONCLUSIONS: This report presents the first case of a gastric bezoar successfully treated by endoscopic fragmentation in combination with Pepsi-Cola® administration, suggesting the possible utility of cola beverages in bezoar treatment, regardless of product brands.
Keywords: Bezoars - therapy, Aged, 80 and over, Carbonated Beverages, Gastroscopy - methods, Stomach
Background
The formation of a bezoar, which is an indigestible conglomeration trapped in the gastrointestinal tract, is a relatively infrequent disorder. Since the first successful treatment achieved with Coca-Cola® lavage reported in 2002 by Ladas et al. [1], the administration of Coca-Cola, in combination with or without endoscopic fragmentation techniques, has been well-known among gastroenterologists as a conservative treatment option for gastric bezoars [2,3]. Bezoar dissolution by Diet Coke®, Coca-Cola Light®, and Coca-Cola Zero® has also been documented in previous reports, suggesting that these sugar-free beverages produce a similar action for bezoar lysis as the regular version of Coca-Cola [4,5]. Despite the clinical success of bezoar dissolution by cola products manufactured by the Coca-Cola Company, to the best of our knowledge, the usefulness of other carbonated beverages such as Pepsi-Cola® has never been reported in the English literature.
We recently treated a patient with a gastric bezoar who presented with coffee-ground emesis. Endoscopic fragmentation was attempted, but it failed because of the solidity of the bezoar. However, lavage with Pepsi NEX Zero® via a nasogastric tube resulted in softening of the bezoar, which was then successfully fragmented by endoscopic polypectomy snare and needle-knife devices. To the best of our knowledge, this report presents the first case of a gastric bezoar treated with endoscopic fragmentation after gastric lavage with Pepsi-Cola.
Case Report
An 86-year-old Taiwanese man underwent esophagogastroduodenoscopy to investigate the coffee-ground emesis that had begun 1 week earlier. The patient had alcoholic liver damage and dementia, but had been taking no medications. He had no previous history of gastrointestinal disease or diabetes mellitus. A physical examination revealed no abnormalities, and there was no evidence of anemia. Laboratory findings revealed a slight elevation of liver enzymes (aspartate amino-transferase [AST], 37 IU/L; gamma-glutamyl transferase [GGT], 120 IU/L), white blood cells (10 190/mcL), and plasma glucose (165 mg/dL). Red blood cells and C-reactive protein were within normal ranges. Esophagogastroduodenoscopy revealed a gastric bezoar, in addition to ulcers in the gastric angle and duodenal bulb (Figure 1). The pyloric ring was stenotic due to the presence of the duodenal ulcer. Endoscopic fragmentation with a polypectomy snare device and removal of the bezoar was attempted twice, but failed because of the solidity of the bezoar.
To dissolve the gastric bezoar, a nasogastric tube was inserted and 500 mL of Pepsi NEX Zero® was administered daily for 4 days via the tube. After the administration of the cola, the bezoar was softened and successfully fragmented by a polypectomy snare and needle-knife devices on the third attempt (Figure 2). The fragments were retrieved by a net device. No component analysis of the bezoar fragments was performed. The patient was assumed to have
Discussion
In 2002, Ladas et al. first reported a case series regarding the efficacy of Coca-Cola in dissolving gastric bezoars [1]. They treated 5 gastric phytobezoar patients with 3 L of Coca-Cola lavage over 12 h via nasogastric tube, and the procedure resulted in complete bezoar dissolution in a single session in all cases. Subsequent successful outcomes by Coca-Cola lavage via a nasogastric tube or by drinking Coca-Cola have been reported by various authors [2–6]. In a recent review article by Ladas et al. [2], 24 publications describing 46 patients were summarized, and the authors noted that bezoar resolution was achieved by Coca-Cola administration in 91.3% of the cases, either as the sole treatment or in combination with additional endoscopic procedures. The cola beverages used to date in the treatment of bezoars include Diet Coke, Coca-Cola Light, Coca-Cola Zero, and regular Coca-Cola [3–6]. However, to the best of our knowledge, the usefulness of other cola products, such as Pepsi-Cola, has never been reported in the English literature. For example, 20 articles and 10 articles are retrieved by searches in PubMed with the terms “bezoar and Coca-Cola” and “phytobezoar and Coca-Cola,” respectively, while no articles were retrieved by searching for “bezoar and Pepsi-Cola” or “phytobezoar and Pepsi-Cola.” Therefore, we believe this to be the first case report showing the clinical utility of beverages produced by PepsiCo.
In the present case, we used Pepsi NEX Zero to dissolve the bezoar. This beverage is a calorie-free product distributed in Japan and South Korea and sold under license from PepsiCo. After lavage with Pepsi NEX Zero for 4 days, the bezoar had softened and was able to be broken by endoscopy devices. In our previous study, similar effects of bezoar softening were observed
The predisposing risk factors of bezoar formation include prior gastric surgery, diabetes mellitus, peptic ulcer disease, carcinoma of the gastrointestinal tract, and hypothyroidism [12–14]. These factors result in reduced gastric acidity, gastric stasis, loss of pyloric function, and/or pyloric stenosis. Elderly individuals are also susceptible to bezoar formation because of their impaired gastric motility [15]. The present patient was of advanced age (86 years old) and had pyloric stenosis due to duodenal ulcers. Although this patient had no previous history of diabetes mellitus, blood examination revealed impaired glucose tolerance. All of these underlying factors would have contributed to delayed gastric emptying and the formation of the bezoar.
Conclusions
In summary, we treated a gastric bezoar patient with endoscopic fragmentation after lavage with Pepsi NEX Zero via a nasogastric tube. Our results indicate that cola beverages, regardless of product brand, are useful in bezoar treatment because they help to dissolve bezoars.
References:
1.. Ladas SD, Triantafyllou K, Tzathas C, Gastric phytobezoars may be treated by nasogastric Coca-Cola lavage: Eur J Gastroenterol Hepatol, 2002; 14; 801-3, pmid: 12169994
2.. Ladas SD, Kamberoglou D, Karamanolis G, Systematic review: Coca-Cola can effectively dissolve gastric phytobezoars as a first-line treatment: Aliment Pharmacol Ther, 2013; 37; 169-73, pmid: 23252775
3.. Iwamuro M, Okada H, Matsueda K: Review of the diagnosis and management of gastrointestinal bezoars World J Gastrointest Endosc [in press]
4.. Ertuğrul G, Coşkun M, Sevinç M, Treatment of gastric phytobezoars with Coca-Cola given via oral route: a case report: Int J Gen Med, 2012; 5; 157-61, pmid: 22393302
5.. Kramer SJ, Pochapin MB, Gastric phytobezoar dissolution with ingestion of diet coke and cellulase: Gastroenterol Hepatol (NY), 2012; 8(11); 770-72
6.. Iwamuro M, Tanaka S, Shiode J, Clinical characteristics and treatment outcomes of nineteen Japanese patients with gastrointestinal bezoars: Intern Med, 2014; 53; 1099-105, pmid: 24881731
7.. Iwamuro M, Kawai Y, Shiraha H: J Clin Gastroenterol, 2014; 48; 190-91, pmid: 24045274
8.. Chung YW, Han DS, Park YK, Huge gastric diospyrobezoars successfully treated by oral intake and endoscopic injection of Coca-Cola: Dig Liver Dis, 2006; 38; 515-17, pmid: 16330268
9.. Sanderson I, Ibberson O, Fish EB, Gastric phytobezoar following gastrectomy: Can Med Assoc J, 1971; 104; 1115, pmid: 5580753
10.. Maekawa T, Onoyama M, Shimada T, [A case of phytobezoars treated by Pepsi Cola ingestion and endoscopic treatment]: Shoukakika, 2007; 45; 345-48 [in Japanese with English abstract]
11.. Mizushige T, Wato M, Inaba T, [Two successful cases of dissolution therapy with carbonated water for gastric phytobezoars]: Gastroenterological Endoscopy, 2014; 56; 3340-46 [in Japanese with English abstract]
12.. Kumar GS, Amar V, Ramesh B, Abbey RK, Bizarre metal bezoar: a case report: Indian J Surg, 2013; 75(Suppl.1); 356-58, pmid: 24426615
13.. LaFountain J, Could your patient’s bowel obstruction be a bezoar?: Todays Surg Nurse, 1999; 21; 34-37, pmid: 10232288
14.. Işik A, Deniz Firat Y, Peker K, How could such a wide piece of tree root pass through the narrow pyloric orifice? An extremely rare case: Am J Case Rep, 2014; 15; 284-87, pmid: 25009689
15.. Sanders MK, Bezoars: from mystical charms to medical and nutritional management: Practical Gastroenterology, 2004; 18; 37-50
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






